Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00323310
Status:
TERMINATED
Last Update Posted:
2010-10-22
First Post:
2006-05-05
Brief Title:
Safety and Efficacy of MultiHance in Pediatric Patients
Sponsor:
Bracco Diagnostics Inc
Organization:
Bracco Diagnostics Inc
Study Overview
Official Title:
A Phase III Multi-Center Open Label Study to Evaluate Safety and Efficacy of MultiHance at the Dose of 010 mmolkg in Magnetic Resonance Imaging of the Central Nervous System in Pediatric Patients
Status:
TERMINATED
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Adequate statistical power at 92 dosed pts to meet study objectives
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study was to assess the safety and enhancing properties of the magnetic resonance imaging MRI contrast agent MultiHance in children aged 2 to 17 years having central nervous system CNS disorders
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None